| 2636 |
105: Inhibition, ETC complexes of the respiratory chain |
1770: Decrease, MMP |
Apr 8, 2022 |
Apr 8, 2022 |
1 AOP
|
| 2821 |
105: Inhibition, ETC complexes of the respiratory chain |
177: Mitochondrial dysfunction |
Jan 5, 2023 |
Jan 5, 2023 |
1 AOP
|
| 475 |
451: Inhibition, Mitochondrial fatty acid beta-oxidation |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 538 |
451: Inhibition, Mitochondrial fatty acid beta-oxidation |
459: Increased, Liver Steatosis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1049 |
1013: Inhibition, Motor neuron activity |
1014: Induction, Somatic muscle paralysis |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 442 |
424: Inhibition, Na+/I- symporter (NIS) |
425: Thyroidal Iodide, Decreased |
Nov 29, 2016 |
May 29, 2018 |
3 AOPs
|
| 552 |
424: Inhibition, Na+/I- symporter (NIS) |
277: TH synthesis, Decreased |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1503 |
424: Inhibition, Na+/I- symporter (NIS) |
341: Impairment, Learning and memory |
May 10, 2017 |
Apr 4, 2019 |
1 AOP
|
| 2232 |
424: Inhibition, Na+/I- symporter (NIS) |
281: T4 in serum, Decreased |
Dec 9, 2020 |
Dec 9, 2020 |
1 AOP
|
| 934 |
887: Inhibition, NADH-ubiquinone oxidoreductase (complex I) |
177: Mitochondrial dysfunction |
Nov 29, 2016 |
Aug 25, 2017 |
1 AOP
|
| 1809 |
887: Inhibition, NADH-ubiquinone oxidoreductase (complex I) |
1477: Decrease, OXPHOS |
Dec 20, 2018 |
Dec 20, 2018 |
1 AOP
|
| 1940 |
887: Inhibition, NADH-ubiquinone oxidoreductase (complex I) |
1545: Decrease in mitochondrial oxidative phosphorylation |
Jun 7, 2019 |
Jun 7, 2019 |
1 AOP
|
| 3241 |
2233: Inhibition, NFAT |
2231: Increased, activation of RAAS |
Jun 7, 2024 |
Jun 7, 2024 |
None
|
| 3242 |
2233: Inhibition, NFAT |
2232: Inhibition, COX-2 activity |
Jun 7, 2024 |
Jun 7, 2024 |
None
|
| 213 |
195: Inhibition, NMDARs |
52: Decreased, Calcium influx |
Nov 29, 2016 |
Apr 7, 2018 |
2 AOPs
|
| 214 |
195: Inhibition, NMDARs |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 215 |
195: Inhibition, NMDARs |
191: Neuronal dysfunction |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 3124 |
195: Inhibition, NMDARs |
2208: Aberrant, synaptic formation and plasticity |
Jan 25, 2024 |
Jan 25, 2024 |
1 AOP
|
| 387 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
152: Suppression, Inflammatory cytokines |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1828 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
1575: Activation, Caspase 8 pathway |
Jan 7, 2019 |
Mar 7, 2019 |
1 AOP
|
| 1871 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
986: Impairment of TDAR |
Mar 12, 2019 |
Mar 12, 2019 |
None
|
| 1921 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
1569: Impaired T cell activation |
May 23, 2019 |
Jun 25, 2019 |
None
|
| 2003 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
1702: Suppression of T cell activation |
Nov 17, 2019 |
Mar 2, 2023 |
1 AOP
|
| 2306 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
1496: Increased proinflammatory mediators |
Mar 30, 2021 |
Mar 30, 2021 |
None
|
| 2644 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
1633: Increase in inflammation |
Apr 8, 2022 |
Apr 8, 2022 |
1 AOP
|